Cardiometabolic Risk Effects of Short-term Cessation of Neurostimulation Therapy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Cardiometabolic Risk Effects of Short-term Cessation of Neurostimulation Therapy — Stella

Recruiting

Back to Obstructive Sleep Apnea trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Columbia University Medical Center, New York, New York

Key details

Sponsor

Columbia University

Collaborators

American Academy of Sleep Medicine, Triological Society

Enrollment target

~60 participants

Started

January 2025

Primary completion

January 2027

Age range

18 Years and older

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov